Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Quanterix Corporation (QTRX)
USD4.15
+0.07 (+1.59%)
US NASDAQ Healthcare Medical - Devices
Address
Building 1 1821
Billerica, MA, US
Billerica, MA, US
CEO
Everett V. Cunningham
Website
quanterix.com
IPO
2017-12-07
CIK 1503274 ISIN US74766Q1013
Description
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Akoya Biosciences, Inc. | AKYA | 2025-02-14 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.15
+0.07 (+1.59%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.12
Float Shares
36.77M
Free Float %
78.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.93% | -7.62% | -13.39% | -50.59% | -44.25% | -54.25% | -49.21% | -81.94% | -93.83% | -83.34% | -83.34% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (10 ratings, all time)
Buy
Price Targets & DCF
Current price
4.15
Low
4.00
-3.5%
Consensus
4.00
-3.5%
Median
4.00
-3.5%
High
4.00
-3.5%
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
4.00
-3.5%
|
| Last Quarter | 1 |
4.00
-3.5%
|
| Last Year | 2 |
6.00
+44.8%
|
| All Time | 6 |
16.67
+302.2%
|
Quality scores
Altman Z-Score
-1.48
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+2.4% Q1'26: +20.3% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%-151.0% Q1'26: +30.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-65.4% Q1'26: -50.0% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-79.2% Q1'26: -59.1% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-51.1% Q1'26: -39.4% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+11.1% Q1'26: +21.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.41× Q1'26: -0.58× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
22.87M
est: 22.82M (+0.3%)
|
37.63M
est: 36.05M (+4.4%)
|
56.73M
est: 55.07M (+3.0%)
|
86.38M
est: 74.82M (+15.4%)
|
110.56M
est: 104.58M (+5.7%)
|
105.52M
est: 105.49M (+0.0%)
|
121.14M
est: 129.33M (-6.3%)
|
135.44M
est: 137.20M (-1.3%)
|
138.65M
est: 133.16M (+4.1%)
|
169.93M
169.34M – 170.52M
+27.6% YoY
|
188.64M
187.14M – 190.13M
+11.0% YoY
|
209.11M
208.81M – 209.41M
+10.8% YoY
|
242.20M
239.76M – 244.43M
+15.8% YoY
|
268.40M
265.69M – 270.87M
+10.8% YoY
|
| EBITDA |
-25.59M
est: -9.37M (-173.1%)
|
-30.20M
est: -14.81M (-104.0%)
|
-38.59M
est: -22.61M (-70.7%)
|
-27.27M
est: -30.73M (+11.2%)
|
-51.64M
est: -42.94M (-20.3%)
|
-67.89M
est: -43.32M (-56.7%)
|
-36.37M
est: -61.90M (+41.2%)
|
-44.26M
est: -65.66M (+32.6%)
|
-90.89M
est: -63.73M (-42.6%)
|
-81.33M
-81.61M – -81.05M
-27.6% YoY
|
-90.29M
-91.00M – -89.57M
-11.0% YoY
|
-100.08M
-100.22M – -99.94M
-10.8% YoY
|
-115.92M
-116.99M – -114.75M
-15.8% YoY
|
-128.46M
-129.64M – -127.16M
-10.8% YoY
|
| EBIT |
-26.07M
est: -10.63M (-145.3%)
|
-31.55M
est: -16.79M (-87.9%)
|
-41.60M
est: -25.65M (-62.2%)
|
-31.58M
est: -34.85M (+9.4%)
|
-56.52M
est: -48.70M (-16.0%)
|
-73.30M
est: -49.13M (-49.2%)
|
-44.66M
est: -71.26M (+37.3%)
|
-52.62M
est: -75.60M (+30.4%)
|
-109.82M
est: -73.37M (-49.7%)
|
-93.63M
-93.96M – -93.31M
-27.6% YoY
|
-103.94M
-104.77M – -103.12M
-11.0% YoY
|
-115.22M
-115.38M – -115.05M
-10.8% YoY
|
-133.45M
-134.68M – -132.11M
-15.8% YoY
|
-147.89M
-149.25M – -146.40M
-10.8% YoY
|
| Net Income |
-27.02M
est: -50.55M (+46.5%)
|
-31.05M
est: -50.12M (+38.1%)
|
-40.80M
est: -63.77M (+36.0%)
|
-31.53M
est: -46.78M (+32.6%)
|
-55.55M
est: -65.40M (+15.1%)
|
-99.57M
est: -98.56M (-1.0%)
|
-28.35M
est: -44.53M (+36.3%)
|
-38.53M
est: -40.33M (+4.5%)
|
-107.15M
est: -96.66M (-10.9%)
|
-54.72M
-55.40M – -54.03M
+43.4% YoY
|
-56.49M
-57.20M – -55.78M
-3.2% YoY
|
-55.23M
-62.39M – -31.00M
+2.2% YoY
|
-60.55M
-61.27M – -59.75M
-9.6% YoY
|
-51.59M
-52.21M – -50.92M
+14.8% YoY
|
| SGA |
19.69M
est: 17.98M (+9.5%)
|
33.78M
est: 28.41M (+18.9%)
|
52.25M
est: 43.39M (+20.4%)
|
59.59M
est: 58.95M (+1.1%)
|
92.91M
est: 82.40M (+12.8%)
|
91.85M
est: 83.12M (+10.5%)
|
92.82M
est: 109.96M (-15.6%)
|
104.64M
est: 116.65M (-10.3%)
|
138.85M
est: 113.22M (+22.6%)
|
144.48M
143.98M – 144.98M
+27.6% YoY
|
160.39M
159.11M – 161.66M
+11.0% YoY
|
177.79M
177.53M – 178.04M
+10.8% YoY
|
205.92M
203.85M – 207.82M
+15.8% YoY
|
228.20M
225.90M – 230.30M
+10.8% YoY
|
| EPS |
-1.24
est: -1.32 (+5.9%)
|
-1.41
est: -1.31 (-7.9%)
|
-1.63
est: -1.66 (+1.9%)
|
-1.07
est: -1.22 (+12.2%)
|
-1.60
est: -1.70 (+6.1%)
|
-2.61
est: -2.58 (-1.2%)
|
-0.86
est: -1.04 (+17.7%)
|
-1.00
est: -0.95 (-5.7%)
|
-2.51
est: -2.27 (-10.7%)
|
-1.28
-1.30 – -1.27
+43.4% YoY
|
-1.33
-1.34 – -1.31
-3.2% YoY
|
-1.05
-1.46 – -0.73
+20.8% YoY
|
-1.42
-1.44 – -1.40
-35.2% YoY
|
-1.21
-1.22 – -1.19
+14.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-04-20 | Canaccord Genuity | Hold | Hold | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-01 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-79.73M
OE per share TTM
-1.76
Owner's Yield
-51.58%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
28.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
19
Total invested
4.04M
Insider transactions (90d)
1
Beneficial owners (>5%)
21
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARCH Venture Fund VIII Overage, L.P. | 3.95M | 18.10% | — | 3.95M | — | 3.95M | PN | Delaware | 2018-02-02 | ↗ |
| 2 | ARCH Venture Partners VI, L.P. | 3.95M | 18.10% | — | 3.95M | — | 3.95M | PN | Delaware | 2018-02-02 | ↗ |
| 3 | Robert Nelsen | 3.95M | 18.10% | — | 3.95M | — | 3.95M | IN | Delaware | 2018-02-02 | ↗ |
| 4 | LLC | 3.35M | 11.94% | — | — | — | 3.35M | BD | New York | 2020-02-14 | ↗ |
| 5 | 10. | 3.15M | 8.61% | — | — | — | — | HC | — | 2022-02-11 | ↗ |
| 6 | ARCH Venture Fund VI, L.P. | 3.12M | 9.90% | — | 3.12M | — | 3.12M | PN | Delaware | 2021-02-02 | ↗ |
| 7 | Gilder, Gagnon, Howe & Co. LLC | 3.08M | 9.71% | — | — | — | — | BD | New York | 2021-02-16 | ↗ |
| 8 | Gilder, Gagnon, Howe & Co. LLC | 3.07M | 13.60% | — | — | — | — | BD | New York | 2019-06-10 | ↗ |
| 9 | Gagnon, Howe & Co. LLC | 2.84M | 7.70% | — | — | — | 2.84M | BD | New York | 2022-02-14 | ↗ |
| 10 | (1) BlackRock, Inc. | 2.46M | 6.70% | 2.42M | — | 2.46M | — | HC | Delaware | 2022-02-04 | ↗ |
| 11 | bioMérieux SA | 2.06M | 9.40% | 2.06M | — | 2.06M | — | CO | France | 2018-02-14 | ↗ |
| 12 | The Vanguard Group - 23-1945930 | 2.06M | 5.43% | — | 33.4K | 1.99M | 63.9K | IA | — | 2024-02-13 | ↗ |
| 13 | Israel A. Englander | 1.99M | 5.30% | — | 1.99M | — | 1.99M | IN | Delaware | 2023-09-29 | ↗ |
| 14 | Millennium Group Management LLC | 1.99M | 5.30% | — | 1.99M | — | 1.99M | OO | Delaware | 2023-09-29 | ↗ |
| 15 | Millennium Management LLC | 1.99M | 5.30% | — | 1.99M | — | 1.99M | OO | Delaware | 2023-09-29 | ↗ |
| 16 | George McCabe | 1.92M | 5.01% | 1.92M | — | 1.92M | — | IN | Delaware | 2024-06-27 | ↗ |
| 17 | Portolan Capital Management, LLC | 1.92M | 5.01% | 1.92M | — | 1.92M | — | IA | Delaware | 2024-06-27 | ↗ |
| 18 | 52-0556948 | 1.44M | 5.20% | 566.6K | — | 1.44M | — | IA | Maryland | 2020-02-14 | ↗ |
| 19 | Abigail P. Johnson | 1.20M | 5.52% | — | — | 1.20M | — | IN | Delaware | 2018-02-13 | ↗ |
| 20 | FMR LLC | 1.20M | 5.52% | 31.5K | — | 1.20M | — | HC | Delaware | 2018-02-13 | ↗ |
| 21 | Cloverdale Capital GP, L.P. | 950.4K | 3.50% | — | 1.87M | — | 1.87M | PN | Delaware | 2018-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
19
-113 vs prev Q
New positions
2
Closed positions
115
Increased
8
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | AMERIPRISE FINANCIAL INC | 5.00M +752.6K (+17.7%) | 31.78M +8.7M (+37.9%) | 10.85% -0.064 pp | 0.01% +0.002 pp | USD10.47 -39.3% | 29 qtrs — |
| 2 | PORTOLAN CAPITAL MANAGEMENT, LLC | 4.53M +265.7K (+6.2%) | 28.78M +5.7M (+24.4%) | 9.83% -1.127 pp | 1.54% +0.291 pp | USD11.58 -45.1% | 15 qtrs — |
| 3 | BLACKROCK, INC. | 3.38M +262.9K (+8.4%) | 21.47M +4.6M (+27.0%) | 7.33% -0.675 pp | 0.00% +0.000 pp | USD12.03 -47.1% | 6 qtrs — |
| 4 | VANGUARD GROUP INC | 2.68M +30.3K (+1.1%) | 17.03M +2.7M (+18.5%) | 5.81% -0.993 pp | 0.00% +0.000 pp | USD26.65 -76.1% | 33 qtrs — |
| 5 | BLUE WATER LIFE SCIENCE ADVISORS, LP | 2.09M +1.1M (+118.4%) | 13.31M +8.1M (+155.9%) | 4.54% +2.080 pp | 8.35% +3.606 pp | USD7.24 -12.2% | 9 qtrs — |
| 6 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.05M +731.2K (+55.6%) | 13.02M +5.9M (+82.2%) | 4.44% +1.061 pp | 0.04% +0.018 pp | USD8.50 -25.2% | 5 qtrs — |
| 7 | INVENOMIC CAPITAL MANAGEMENT LP | 1.51M +112.2K (+8.1%) | 9.57M +2.0M (+26.6%) | 3.27% -0.314 pp | 0.45% +0.079 pp | USD6.34 +0.3% | 4 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.07M +62.1K (+6.1%) | 6.83M +1.3M (+24.3%) | 2.33% -0.270 pp | 0.00% +0.000 pp | USD26.57 -76.1% | 32 qtrs — |
| 9 | STATE STREET CORP | 893.4K +73.9K (+9.0%) | 5.68M +1.2M (+27.7%) | 1.94% -0.168 pp | 0.00% +0.000 pp | USD28.42 -77.6% | 32 qtrs — |
| 10 | MORGAN STANLEY | 823.0K +16.7K (+2.1%) | 5.23M +856.3K (+19.6%) | 1.79% -0.286 pp | 0.00% +0.000 pp | USD9.67 -34.2% | 33 qtrs — |
| 11 | TRIUM CAPITAL LLP | 817.5K +128.9K (+18.7%) | 5.20M +1.5M (+39.0%) | 1.77% +0.004 pp | 4.03% +2.572 pp | USD6.36 +0.0% | 4 qtrs — |
| 12 | WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 638.9K -47.5K (-6.9%) | 4.06M +336.2K (+9.0%) | 1.39% -0.378 pp | 0.05% +0.003 pp | USD11.32 -43.8% | 8 qtrs — |
| 13 | EMPIRE FINANCIAL MANAGEMENT COMPANY, LLC | 617.8K +165.4K (+36.6%) | 3.93M +1.5M (+59.9%) | 1.34% +0.178 pp | 0.85% +0.291 pp | USD6.60 -3.6% | 9 qtrs — |
| 14 | EASTERLY INVESTMENT PARTNERS LLC | 616.7K -635.5K (-50.8%) | 3.92M -2.9M (-42.3%) | 1.34% -1.881 pp | 0.24% -0.219 pp | USD10.74 -40.8% | 9 qtrs — |
| 15 | TIKVAH MANAGEMENT LLC | 571.6K +— (+0.0%) | 3.64M +531.6K (+17.1%) | 1.24% -0.229 pp | 0.97% +0.055 pp | USD21.14 -69.9% | 29 qtrs — |
| 16 | FIRST EAGLE INVESTMENT MANAGEMENT, LLC | 531.4K +531.4K (+100.0%) | 3.38M +3.4M (+100.0%) | 1.15% +1.154 pp | 0.01% +0.006 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 17 | MILLENNIUM MANAGEMENT LLC | 402.6K -806.6K (-66.7%) | 2.56M -4.0M (-61.0%) | 0.87% -2.235 pp | 0.00% -0.002 pp | USD5.58 +14.0% | 33 qtrs — |
| 18 | DIMENSIONAL FUND ADVISORS LP | 389.5K -317.6K (-44.9%) | 2.48M -1.4M (-35.5%) | 0.85% -0.972 pp | 0.00% 0.000 pp | USD23.53 -73.0% | 21 qtrs — |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 362.7K +31.5K (+9.5%) | 2.31M +508.4K (+28.3%) | 0.79% -0.064 pp | 0.00% +0.000 pp | USD26.45 -76.0% | 32 qtrs — |
| 20 | NORTHERN TRUST CORP | 345.6K -8.1K (-2.3%) | 2.20M +277.4K (+14.4%) | 0.75% -0.159 pp | 0.00% +0.000 pp | USD25.31 -74.9% | 32 qtrs — |
| 21 | PARKMAN HEALTHCARE PARTNERS LLC | 329.0K +76.7K (+30.4%) | 2.09M +722.7K (+52.8%) | 0.71% +0.066 pp | 0.20% +0.056 pp | USD6.58 -3.3% | 3 qtrs — |
| 22 | UBS GROUP AG | 311.5K -62.1K (-16.6%) | 1.98M -47.5K (-2.3%) | 0.68% -0.284 pp | 0.00% +0.000 pp | USD10.21 -37.7% | 33 qtrs — |
| 23 | TWO SIGMA INVESTMENTS, LP | 258.9K +8.8K (+3.5%) | 1.65M +288.4K (+21.2%) | 0.56% -0.081 pp | 0.00% +0.000 pp | USD7.44 -14.5% | 5 qtrs — |
| 24 | RUSSELL INVESTMENTS GROUP, LTD. | 256.1K -177.9K (-41.0%) | 1.63M -727.9K (-30.9%) | 0.56% -0.560 pp | 0.00% -0.001 pp | USD10.32 -38.4% | 12 qtrs — |
| 25 | ENVESTNET ASSET MANAGEMENT INC | 252.2K -263.7K (-51.1%) | 1.60M -1.2M (-42.7%) | 0.55% -0.779 pp | 0.00% 0.000 pp | USD7.80 -18.5% | 8 qtrs — |
| 26 | GOLDMAN SACHS GROUP INC | 248.2K -29.8K (-10.7%) | 1.58M +68.9K (+4.6%) | 0.54% -0.176 pp | 0.00% +0.000 pp | USD18.83 -66.2% | 33 qtrs — |
| 27 | IRONWOOD INVESTMENT MANAGEMENT LLC | 172.3K -21.7K (-11.2%) | 1.10M +42.2K (+4.0%) | 0.37% -0.125 pp | 0.46% +0.001 pp | USD5.56 +14.4% | 3 qtrs — |
| 28 | TUDOR INVESTMENT CORP ET AL | 169.7K +169.7K (+100.0%) | 1.08M +1.1M (+100.0%) | 0.37% +0.368 pp | 0.00% +0.002 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 29 | BNP PARIBAS ARBITRAGE, SNC | 168.4K +18.1K (+12.0%) | 1.07M +254.9K (+31.2%) | 0.37% -0.021 pp | 0.00% +0.000 pp | USD6.11 +4.1% | 32 qtrs — |
| 30 | WELLS FARGO & COMPANY/MN | 162.7K +18.4K (+12.7%) | 1.03M +251.0K (+32.0%) | 0.35% -0.018 pp | 0.00% +0.000 pp | USD11.43 -44.4% | 33 qtrs — |
| 31 | FMR LLC | 159.9K +42.8K (+36.5%) | 1.02M +381.0K (+59.9%) | 0.35% +0.046 pp | 0.00% +0.000 pp | USD9.72 -34.6% | 33 qtrs — |
| 32 | MARSHALL WACE, LLP | 155.2K -453.5K (-74.5%) | 986.9K -2.3M (-70.1%) | 0.34% -1.228 pp | 0.00% -0.003 pp | USD6.32 +0.6% | 3 qtrs — |
| 33 | STATE OF WISCONSIN INVESTMENT BOARD | 147.8K -47.9K (-24.5%) | 940.2K -122.8K (-11.6%) | 0.32% -0.182 pp | 0.00% 0.000 pp | USD9.98 -36.3% | 14 qtrs — |
| 34 | JUMP FINANCIAL, LLC | 144.1K +25.7K (+21.8%) | 916.4K +273.8K (+42.6%) | 0.31% +0.009 pp | 0.01% +0.004 pp | USD6.50 -2.2% | 6 qtrs — |
| 35 | BANK OF NEW YORK MELLON CORP | 123.5K +6.0K (+5.1%) | 785.6K +147.4K (+23.1%) | 0.27% -0.034 pp | 0.00% +0.000 pp | USD30.16 -78.9% | 31 qtrs — |
| 36 | GSA CAPITAL PARTNERS LLP | 121.5K +121.5K (+100.0%) | 773.0K +773.0K (+100.0%) | 0.26% +0.264 pp | 0.07% +0.067 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 37 | BARCLAYS PLC | 120.2K -26.0K (-17.8%) | 764.5K -1.1M (-59.7%) | 0.26% -0.115 pp | 0.00% 0.000 pp | USD9.88 -35.6% | 32 qtrs — |
| 38 | SCS CAPITAL MANAGEMENT LLC | 120.0K +— (+0.0%) | 763.4K +111.6K (+17.1%) | 0.26% -0.048 pp | 0.01% +0.001 pp | USD6.51 -2.3% | 4 qtrs — |
| 39 | JPMORGAN CHASE & CO | 114.0K -113.8K (-49.9%) | 725.2K -511.6K (-41.4%) | 0.25% -0.338 pp | 0.00% +0.000 pp | USD19.11 -66.7% | 32 qtrs — |
| 40 | INVESCO LTD. | 113.2K +14.5K (+14.7%) | 720.0K +184.1K (+34.3%) | 0.25% -0.008 pp | 0.00% +0.000 pp | USD10.90 -41.7% | 27 qtrs — |
| 41 | CITIGROUP INC | 112.4K -106.2K (-48.6%) | 714.7K -472.1K (-39.8%) | 0.24% -0.318 pp | 0.00% 0.000 pp | USD7.71 -17.5% | 31 qtrs — |
| 42 | ABRDN PLC | 104.0K -460.5K (-81.6%) | 661.7K -2.4M (-78.4%) | 0.23% -1.226 pp | 0.00% -0.004 pp | USD8.81 -27.8% | 8 qtrs — |
| 43 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 103.6K -38.3K (-27.0%) | 659.1K -111.8K (-14.5%) | 0.23% -0.140 pp | 0.00% +0.000 pp | USD7.56 -15.9% | 21 qtrs — |
| 44 | AMERICAN CENTURY COMPANIES INC | 103.2K +5.6K (+5.7%) | 656.4K +126.5K (+23.9%) | 0.22% -0.027 pp | 0.00% +0.000 pp | USD15.06 -57.8% | 12 qtrs — |
| 45 | ROYAL BANK OF CANADA | 101.0K -146.7K (-59.2%) | 642.0K -703.0K (-52.3%) | 0.22% -0.418 pp | 0.00% 0.000 pp | USD10.96 -42.0% | 33 qtrs — |
| 46 | CITADEL ADVISORS LLC | 98.6K +15.4K (+18.5%) | 626.9K +175.2K (+38.8%) | 0.21% +0.000 pp | 0.00% +0.000 pp | USD5.58 +14.0% | 21 qtrs — |
| 47 | TWO SIGMA ADVISERS, LP | 86.9K -55.3K (-38.9%) | 552.6K -219.5K (-28.4%) | 0.19% -0.177 pp | 0.00% -0.001 pp | USD7.79 -18.4% | 20 qtrs — |
| 48 | XTX TOPCO LTD | 74.1K +62.8K (+555.1%) | 471.2K +409.8K (+667.3%) | 0.16% +0.132 pp | 0.01% +0.009 pp | USD6.57 -3.2% | 7 qtrs — |
| 49 | NUVEEN, LLC | 71.5K +— (+0.0%) | 454.5K +66.5K (+17.1%) | 0.16% -0.029 pp | 0.00% +0.000 pp | USD6.51 -2.3% | 4 qtrs — |
| 50 | JANE STREET GROUP, LLC | 69.4K -80.4K (-53.7%) | 441.3K -372.0K (-45.7%) | 0.15% -0.235 pp | 0.00% 0.000 pp | USD11.24 -43.4% | 12 qtrs — |
| 51 | AQR CAPITAL MANAGEMENT LLC | 65.5K -92.5K (-58.5%) | 416.7K -441.1K (-51.4%) | 0.14% -0.264 pp | 0.00% 0.000 pp | USD9.81 -35.2% | 21 qtrs — |
| 52 | QUANTINNO CAPITAL MANAGEMENT LP | 63.8K +36.3K (+131.9%) | 405.7K +256.3K (+171.6%) | 0.14% +0.068 pp | 0.00% +0.000 pp | USD6.47 -1.7% | 4 qtrs — |
| 53 | CLARIUS GROUP, LLC | 62.1K +— (+0.0%) | 394.7K +57.7K (+17.1%) | 0.13% -0.025 pp | 0.02% +0.003 pp | USD16.19 -60.7% | 15 qtrs — |
| 54 | SCHONFELD STRATEGIC ADVISORS LLC | 61.7K -74.9K (-54.8%) | 392.6K -349.1K (-47.1%) | 0.13% -0.217 pp | 0.00% -0.003 pp | USD6.65 -4.4% | 3 qtrs — |
| 55 | MOUNT LUCAS MANAGEMENT LP | 56.5K -3.5K (-5.8%) | 359.3K +33.5K (+10.3%) | 0.12% -0.032 pp | 0.14% +0.010 pp | USD6.55 -2.9% | 4 qtrs — |
| 56 | SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 55.2K -42.5K (-43.5%) | 350.8K -179.6K (-33.9%) | 0.12% -0.131 pp | 0.01% -0.003 pp | USD6.65 -4.4% | 3 qtrs — |
| 57 | RHUMBLINE ADVISERS | 55.1K -1.9K (-3.4%) | 350.5K +40.7K (+13.1%) | 0.12% -0.027 pp | 0.00% +0.000 pp | USD22.67 -71.9% | 29 qtrs — |
| 58 | PEDDOCK CAPITAL ADVISORS, LLC | 52.1K +— (+0.0%) | 331.4K +48.5K (+17.1%) | 0.11% -0.021 pp | 0.07% +0.008 pp | USD5.84 +8.9% | 3 qtrs — |
| 59 | PDT PARTNERS, LLC | 47.7K +— (+0.0%) | 303.2K +44.3K (+17.1%) | 0.10% -0.019 pp | 0.02% +0.003 pp | USD6.65 -4.4% | 3 qtrs — |
| 60 | D. E. SHAW & CO., INC. | 45.6K +45.6K (+100.0%) | 290.2K +290.2K (+100.0%) | 0.10% +0.099 pp | 0.00% +0.000 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 61 | ALLIANCEBERNSTEIN L.P. | 44.5K +— (+0.0%) | 282.9K +41.4K (+17.1%) | 0.10% -0.018 pp | 0.00% +0.000 pp | USD19.04 -66.6% | 28 qtrs — |
| 62 | PRICE T ROWE ASSOCIATES INC /MD/ | 43.8K -15.0K (-25.5%) | 279.0K -41.0K (-12.8%) | 0.10% -0.056 pp | 0.00% +0.000 pp | USD18.94 -66.4% | 33 qtrs — |
| 63 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 43.0K +— (+0.0%) | 273.5K +40.0K (+17.1%) | 0.09% -0.017 pp | 0.01% +0.001 pp | USD5.43 +17.1% | 2 qtrs — |
| 64 | BANK OF AMERICA CORP /DE/ | 42.5K -45.8K (-51.9%) | 270.6K -209.2K (-43.6%) | 0.09% -0.135 pp | 0.00% +0.000 pp | USD15.07 -57.8% | 33 qtrs — |
| 65 | DEUTSCHE BANK AG\ | 29.9K +1.8K (+6.5%) | 190.2K +37.7K (+24.7%) | 0.06% -0.007 pp | 0.00% +0.000 pp | USD11.51 -44.7% | 32 qtrs — |
| 66 | NUMERAI GP LLC | 29.8K -58.3K (-66.2%) | 189.3K -288.9K (-60.4%) | 0.06% -0.162 pp | 0.02% -0.045 pp | USD5.43 +17.1% | 4 qtrs — |
| 67 | LOS ANGELES CAPITAL MANAGEMENT LLC | 35.0K +35.0K (+100.0%) | 174.9K +174.9K (+100.0%) | 0.08% +0.076 pp | 0.00% +0.001 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 68 | PEAK6 LLC | 26.4K +26.4K (+100.0%) | 167.9K +167.9K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 69 | PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 25.0K -75.7K (-75.2%) | 159.0K -387.6K (-70.9%) | 0.05% -0.205 pp | 0.33% -0.646 pp | USD5.43 +17.1% | 4 qtrs — |
| 70 | LPL FINANCIAL LLC | 24.9K +24.9K (+100.0%) | 158.2K +158.2K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.000 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 71 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 24.1K +24.1K (+100.0%) | 153.1K +153.1K (+100.0%) | 0.05% +0.052 pp | 0.00% +0.001 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 72 | ADVISOR GROUP HOLDINGS, INC. | 23.2K -1.5K (-6.1%) | 147.7K +34.8K (+30.8%) | 0.05% -0.013 pp | 0.00% +0.000 pp | USD10.72 -40.7% | 21 qtrs — |
| 73 | QUADRATURE CAPITAL LTD | 21.7K +21.7K (+100.0%) | 138.1K +138.1K (+100.0%) | 0.05% +0.047 pp | 0.00% +0.001 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 74 | VIRTU FINANCIAL LLC | 20.6K +20.6K (+100.0%) | 131.0K +131.0K (+100.0%) | 0.04% +0.045 pp | 0.01% +0.005 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 75 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 20.5K +1.4K (+7.2%) | 130.2K +26.5K (+25.5%) | 0.04% -0.005 pp | 0.00% +0.000 pp | USD11.98 -46.9% | 7 qtrs — |
| 76 | INTECH INVESTMENT MANAGEMENT LLC | 19.1K -96.0 (-0.5%) | 121.3K +17.2K (+16.5%) | 0.04% -0.008 pp | 0.00% +0.000 pp | USD9.93 -36.0% | 6 qtrs — |
| 77 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 16.8K -6.4K (-27.7%) | 106.8K -19.4K (-15.3%) | 0.04% -0.023 pp | 0.00% +0.001 pp | USD6.19 +2.7% | 3 qtrs — |
| 78 | METLIFE INVESTMENT MANAGEMENT, LLC | 16.0K -7.0K (-30.4%) | 101.6K -23.0K (-18.5%) | 0.03% -0.024 pp | 0.00% 0.000 pp | USD28.21 -77.5% | 27 qtrs — |
| 79 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 15.6K +1.5K (+10.3%) | 100.1K +23.5K (+30.7%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD6.50 -2.2% | 17 qtrs — |
| 80 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 14.1K +327.0 (+2.4%) | 89.9K +14.9K (+19.9%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD27.46 -76.8% | 23 qtrs — |
| 81 | TCG ADVISORY SERVICES, LLC | 13.7K +1.5K (+12.3%) | 86.9K +20.9K (+31.6%) | 0.03% -0.002 pp | 0.00% +0.000 pp | USD6.62 -3.9% | 3 qtrs — |
| 82 | VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 13.2K +164.0 (+1.3%) | 83.8K +13.1K (+18.6%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD6.55 -2.9% | 4 qtrs — |
| 83 | HRT FINANCIAL LP | 13.0K +13.0K (+100.0%) | 82.0K +82.0K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.000 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 84 | JAIN GLOBAL LLC | 12.7K -4.7K (-27.0%) | 80.6K -13.7K (-14.6%) | 0.03% -0.017 pp | 0.00% 0.000 pp | USD5.43 +17.1% | 4 qtrs — |
| 85 | DEKABANK DEUTSCHE GIROZENTRALE | 4.6K +— (+0.0%) | 80.0K +1.0K (+1.3%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD27.14 -76.6% | 10 qtrs — |
| 86 | RENAISSANCE TECHNOLOGIES LLC | 11.8K +11.8K (+100.0%) | 75.0K +75.0K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.000 pp | USD6.36 +0.0% | 21 qtrs — |
| 87 | POST RESCH TALLON GROUP INC. | 11.6K -500.0 (-4.1%) | 73.6K +8.1K (+12.3%) | 0.03% -0.006 pp | 0.06% +0.004 pp | USD10.63 -40.2% | 5 qtrs — |
| 88 | COMMONWEALTH EQUITY SERVICES, LLC | 11.2K -6.2K (-35.7%) | 71.5K -23.5K (-24.8%) | 0.02% -0.021 pp | 0.00% +0.000 pp | USD6.51 -2.3% | 4 qtrs — |
| 89 | AXQ CAPITAL, LP | 11.0K +11.0K (+100.0%) | 70.0K +70.0K (+100.0%) | 0.02% +0.024 pp | 0.02% +0.016 pp | USD6.36 +0.0% | 1 qtrs NEW |
| 90 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 10.1K +— (+0.0%) | 64.0K +9.4K (+17.1%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD10.63 -40.2% | 5 qtrs — |
| 91 | NEW YORK STATE COMMON RETIREMENT FUND | 6.5K +— (+0.0%) | 41.3K +6.0K (+17.1%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD29.79 -78.7% | 31 qtrs — |
| 92 | US BANCORP \DE\ | 6.4K +6.3K (+16,200.0%) | 40.4K +40.2K (+18,970.8%) | 0.01% +0.014 pp | 0.00% +0.000 pp | USD6.44 -1.2% | 23 qtrs — |
| 93 | FARTHER FINANCE ADVISORS, LLC | 4.1K +4.1K (+100.0%) | 25.9K +25.9K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD6.36 +0.0% | 9 qtrs — |
| 94 | LEGAL & GENERAL GROUP PLC | 4.0K +686.0 (+20.7%) | 25.4K +7.4K (+41.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD25.58 -75.1% | 32 qtrs — |
| 95 | AMERITAS INVESTMENT PARTNERS, INC. | 3.5K +— (+0.0%) | 22.1K +3.2K (+17.1%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD32.70 -80.6% | 32 qtrs — |
| 96 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2.7K +180.0 (+7.1%) | 17.3K +3.5K (+25.4%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD37.15 -82.9% | 32 qtrs — |
| 97 | STERLING CAPITAL MANAGEMENT LLC | 2.3K -256.0 (-9.9%) | 14.8K +770.0 (+5.5%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD6.73 -5.5% | 6 qtrs — |
| 98 | CWM, LLC | 2.0K +658.0 (+50.9%) | 12.0K +5.0K (+71.4%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD12.77 -50.2% | 17 qtrs — |
| 99 | VERSANT CAPITAL MANAGEMENT, INC | 1.8K +357.0 (+25.1%) | 11.3K +3.6K (+46.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.84 -7.0% | 5 qtrs — |
| 100 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.6K -1.4K (-46.5%) | 10.3K -6.1K (-37.3%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD8.88 -28.4% | 23 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 52 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.63% | 139.1K | 0.20% |
| 2 | iShares Micro-Cap ETF IWC | 0.04% | 556.4K | 0.60% |
| 3 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.03% | 305.5K | 0.20% |
| 4 | Invesco RAFI US 1500 Small-Mid ETF PRFZ | 0.01% | 370.2K | 0.34% |
| 5 | Fidelity Enhanced Small Cap ETF FESM | 0.01% | 751.4K | 0.28% |
| 6 | iShares Biotechnology ETF IBB | 0.01% | 1.11M | 0.44% |
| 7 | Invesco Russell 2000 Dynamic Multifactor ETF OMFS | 0.01% | 33.0K | 0.39% |
| 8 | Avantis U.S. Small Cap Equity ETF AVSC | 0.01% | 347.5K | 0.25% |
| 9 | iShares Russell 2000 Value ETF IWN | 0.01% | 1.50M | 0.24% |
| 10 | U.S. Micro Cap Portfolio ETF DFMC | 0.01% | 646.4K | 0.43% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.61
Neutral
Ratio by volume
3.00
Bullish
Buys
11
Sells
18
Shares acquired
14.0K
Shares disposed
4.6K
Cash buys
—
Cash sales
—
Net activity
+9,434
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | Miller Michael Francis | Officer | M-Exempt | A | Common Stock | 130 | 0.00 | — | 32,652 | D | ↗ |
| 2026-04-15 | Sriram Vandana | Officer | M-Exempt | D | Restricted Stock Unit | 263 | 0.00 | — | 4,208 | D | ↗ |
| 2026-04-15 | Miller Michael Francis | Officer | M-Exempt | D | Restricted Stock Unit | 372 | 0.00 | — | 9,317 | D | ↗ |
| 2026-04-01 | Mendel Scott | Director | A-Award | A | Common Stock | 4,310 | 0.00 | — | 12,527 | D | ↗ |
| 2026-04-01 | DONNELLY WILLIAM P | Director / Officer | A-Award | A | Common Stock | 6,178 | 0.00 | — | 154,127 | D | ↗ |
| 2026-03-31 | Miller Michael Francis | Officer | M-Exempt | D | Restricted Stock Unit | 99 | 0.00 | — | 0 | D | ↗ |
| 2026-03-15 | Sriram Vandana | Officer | M-Exempt | D | Restricted Stock Unit | 263 | 0.00 | — | 4,471 | D | ↗ |
| 2026-03-15 | Miller Michael Francis | Officer | M-Exempt | D | Restricted Stock Unit | 834 | 0.00 | — | 8,855 | D | ↗ |
| 2026-02-23 | Miller Michael Francis | Officer | — | — | Stock Options (Right to buy) | 21,852 | 23.10 | 504.8K | 0 | D | ↗ |
| 2026-02-23 | Char Daniel | Officer | — | — | Stock Options (Right to buy) | 113,171 | 7.95 | 899.7K | 0 | D | ↗ |
| 2026-02-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 92 | 5.74 | 528.08 | 26,240 | D | ↗ |
| 2026-02-04 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 4,395 | 0.00 | — | 81,618 | D | ↗ |
| 2026-01-19 | Cunningham Everett | Director / Officer | A-Award | A | Time-Based Restricted Stock Units | 1,070,000 | 0.00 | — | 1,883,750 | D | ↗ |
| 2026-01-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,817 | 7.95 | 14.4K | 507,310 | D | ↗ |
| 2026-01-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 274 | 7.95 | 2.2K | 86,013 | D | ↗ |
| 2026-01-02 | WALT DAVID R | Director | A-Award | A | Common Stock | 1,215 | 0.00 | — | 1,872,890 | D | ↗ |
| 2026-01-02 | Sachs Alan Bruce | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 70,099 | D | ↗ |
| 2026-01-02 | Mendel Scott | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 54,109 | D | ↗ |
| 2026-01-02 | Magovcevic-Liebisch Ivana | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 43,607 | D | ↗ |
| 2026-01-02 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 3,974 | 0.00 | — | 313,253 | D | ↗ |
| 2026-01-02 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 52,860 | D | ↗ |
| 2026-01-02 | Hampton Malcolm Garret | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 70,099 | D | ↗ |
| 2026-01-02 | Flynn Karen | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 57,212 | D | ↗ |
| 2026-01-02 | Elliott Jeffrey Thomas | Director | A-Award | A | Common Stock | 23,372 | 0.00 | — | 42,792 | D | ↗ |
| 2026-01-02 | DONNELLY WILLIAM P | Director / Officer | A-Award | A | Common Stock | 2,377 | 0.00 | — | 150,751 | D | ↗ |
| 2025-12-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 258 | 6.36 | 1.6K | 508,446 | D | ↗ |
| 2025-12-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 7.41 | 9.2K | 508,704 | D | ↗ |
| 2025-12-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 7.41 | 1.7K | 85,977 | D | ↗ |
| 2025-11-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 7.26 | 1.8K | 509,946 | D | ↗ |
| 2025-11-24 | Hampton Malcolm Garret | Director | — | — | No securities beneficially held | 0 | 0.00 | — | 0 | D | ↗ |
| 2025-11-20 | Sachs Alan Bruce | Director | A-Award | A | Common Stock | 46,727 | 0.00 | — | 46,727 | D | ↗ |
| 2025-11-20 | Hampton Malcolm Garret | Director | A-Award | A | Common Stock | 46,727 | 0.00 | — | 46,727 | D | ↗ |
| 2025-11-20 | DONNELLY WILLIAM P | Director / Officer | A-Award | A | Stock Options (Right to buy) | 70,091 | 5.91 | 414.2K | 70,091 | D | ↗ |
| 2025-11-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 5.74 | 7.1K | 510,200 | D | ↗ |
| 2025-11-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 5.78 | 1.3K | 86,206 | D | ↗ |
| 2025-10-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 5.34 | 1.4K | 511,442 | D | ↗ |
| 2025-10-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 5.78 | 7.2K | 511,696 | D | ↗ |
| 2025-10-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 5.78 | 1.3K | 86,742 | D | ↗ |
| 2025-10-01 | WALT DAVID R | Director | A-Award | A | Common Stock | 2,594 | 5.54 | 14.4K | 1,871,675 | D | ↗ |
| 2025-10-01 | Mendel Scott | Director | A-Award | A | Common Stock | 2,084 | 5.54 | 11.5K | 30,737 | D | ↗ |
| 2025-10-01 | LAI GOLDMAN MYLA | Director | A-Award | A | Common Stock | 2,084 | 5.54 | 11.5K | 29,488 | D | ↗ |
| 2025-10-01 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 5,076 | 5.54 | 28.1K | 148,374 | D | ↗ |
| 2025-09-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 5.43 | 1.4K | 512,938 | D | ↗ |
| 2025-09-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 4.97 | 6.2K | 513,192 | D | ↗ |
| 2025-09-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 4.97 | 1.1K | 86,971 | D | ↗ |
| 2025-09-12 | Sriram Vandana | Officer | P-Purchase | A | Common Stock | 4,150 | 4.79 | 19.9K | 87,200 | D | ↗ |
| 2025-08-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 4.55 | 1.2K | 514,434 | D | ↗ |
| 2025-08-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 4.57 | 5.7K | 514,688 | D | ↗ |
| 2025-08-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 4.57 | 1.0K | 83,050 | D | ↗ |
| 2025-07-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 5.94 | 1.5K | 515,930 | D | ↗ |
| 2025-07-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 5.49 | 6.8K | 516,184 | D | ↗ |
| 2025-07-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 5.49 | 1.3K | 83,279 | D | ↗ |
| 2025-07-08 | Mendel Scott | Director | A-Award | A | Stock Option (right to buy) | 50,758 | 6.54 | 332.0K | 50,758 | D | ↗ |
| 2025-07-08 | LAI GOLDMAN MYLA | Director | A-Award | A | Stock Option (right to buy) | 50,758 | 6.54 | 332.0K | 50,758 | D | ↗ |
| 2025-07-01 | WALT DAVID R | Director | A-Award | A | Common Stock | 2,148 | 6.69 | 14.4K | 1,869,081 | D | ↗ |
| 2025-07-01 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 2,242 | 6.69 | 15.0K | 309,279 | D | ↗ |
| 2025-07-01 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 2,615 | 6.69 | 17.5K | 60,070 | D | ↗ |
| 2025-07-01 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 4,204 | 6.69 | 28.1K | 143,298 | D | ↗ |
| 2025-06-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 6.65 | 1.7K | 517,426 | D | ↗ |
| 2025-06-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 6.06 | 7.5K | 517,680 | D | ↗ |
| 2025-06-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 6.06 | 1.4K | 83,508 | D | ↗ |
| 2025-06-13 | WALT DAVID R | Director | P-Purchase | A | Common Stock | 123,990 | 6.14 | 760.8K | 1,866,933 | D | ↗ |
| 2025-06-12 | WALT DAVID R | Director | P-Purchase | A | Common Stock | 36,010 | 6.23 | 224.2K | 1,742,943 | D | ↗ |
| 2025-06-09 | WALT DAVID R | Director | P-Purchase | A | Common Stock | 78,131 | 5.34 | 417.2K | 1,706,933 | D | ↗ |
| 2025-06-09 | Toloue Masoud | Director / Officer | P-Purchase | A | Common Stock | 45,900 | 5.42 | 248.7K | 518,922 | D | ↗ |
| 2025-06-06 | WALT DAVID R | Director | P-Purchase | A | Common Stock | 131,869 | 5.43 | 716.6K | 1,628,802 | D | ↗ |
| 2025-06-06 | DONNELLY WILLIAM P | Director | P-Purchase | A | Common Stock | 93,113 | 5.44 | 506.3K | 139,094 | D | ↗ |
| 2025-05-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 5.20 | 1.3K | 473,022 | D | ↗ |
| 2025-05-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 4.50 | 5.6K | 473,276 | D | ↗ |
| 2025-05-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 4.50 | 1.0K | 83,737 | D | ↗ |
| 2025-04-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 5.76 | 1.5K | 474,518 | D | ↗ |
| 2025-04-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 5.16 | 6.4K | 474,772 | D | ↗ |
| 2025-04-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 5.36 | 1.2K | 83,966 | D | ↗ |
| 2025-04-01 | WALT DAVID R | Director | A-Award | A | Common Stock | 2,156 | 6.67 | 14.4K | 1,496,933 | D | ↗ |
| 2025-04-01 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 2,479 | 6.67 | 16.5K | 307,037 | D | ↗ |
| 2025-04-01 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 2,625 | 6.67 | 17.5K | 57,455 | D | ↗ |
| 2025-04-01 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 2,681 | 6.67 | 17.9K | 45,981 | D | ↗ |
| 2025-03-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 254 | 6.51 | 1.7K | 476,014 | D | ↗ |
| 2025-03-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,242 | 7.06 | 8.8K | 476,268 | D | ↗ |
| 2025-03-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 229 | 7.06 | 1.6K | 84,195 | D | ↗ |
| 2025-02-28 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 247 | 7.59 | 1.9K | 477,510 | D | ↗ |
| 2025-02-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 752 | 8.05 | 6.1K | 477,757 | D | ↗ |
| 2025-02-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 92 | 8.05 | 740.60 | 84,424 | D | ↗ |
| 2025-02-04 | Toloue Masoud | Director / Officer | A-Award | A | Common Stock | 138,790 | 0.00 | — | 478,509 | D | ↗ |
| 2025-02-04 | Sriram Vandana | Officer | A-Award | A | Stock Option (right to buy) | 166,119 | 8.43 | 1.40M | 166,119 | D | ↗ |
| 2025-02-02 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 6,077 | 9.19 | 55.8K | 339,719 | D | ↗ |
| 2025-02-02 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 2,166 | 9.19 | 19.9K | 33,804 | D | ↗ |
| 2025-01-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 298 | 9.19 | 2.7K | 345,796 | D | ↗ |
| 2025-01-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 906 | 8.62 | 7.8K | 346,094 | D | ↗ |
| 2025-01-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 93 | 8.62 | 801.66 | 35,970 | D | ↗ |
| 2025-01-02 | WALT DAVID R | Director | A-Award | A | Stock Option (Right to Buy) | 15,821 | 10.76 | 170.2K | 15,821 | D | ↗ |
| 2025-01-02 | Magovcevic-Liebisch Ivana | Director | A-Award | A | Common Stock | 7,435 | 0.00 | — | 20,235 | D | ↗ |
| 2025-01-02 | Madaus Martin D | Director | A-Award | A | Common Stock | 7,435 | 0.00 | — | 36,908 | D | ↗ |
| 2025-01-02 | MEISTER PAUL M | Director | A-Award | A | Stock Options (Right to buy) | 15,821 | 10.76 | 170.2K | 15,821 | D | ↗ |
| 2025-01-02 | Hlavinka Sarah E. | Director | A-Award | A | Stock Options (Right to buy) | 15,821 | 10.76 | 170.2K | 15,821 | D | ↗ |
| 2025-01-02 | Flynn Karen | Director | A-Award | A | Stock Option (Right to Buy) | 15,821 | 10.76 | 170.2K | 15,821 | D | ↗ |
| 2025-01-02 | Elliott Jeffrey Thomas | Director | A-Award | A | Common Stock | 7,435 | 0.00 | — | 19,420 | D | ↗ |
| 2025-01-02 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 1,282 | 10.76 | 13.8K | 43,300 | D | ↗ |
| 2024-12-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 415 | 10.63 | 4.4K | 347,000 | D | ↗ |
| 2024-12-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 752 | 10.68 | 8.0K | 347,415 | D | ↗ |
| 2024-12-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 75 | 10.68 | 801.00 | 36,063 | D | ↗ |
| 2024-11-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 368 | 12.33 | 4.5K | 348,167 | D | ↗ |
| 2024-11-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 11.44 | 12.8K | 348,535 | D | ↗ |
| 2024-11-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 78 | 11.44 | 892.32 | 36,138 | D | ↗ |
| 2024-10-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 368 | 13.22 | 4.9K | 349,655 | D | ↗ |
| 2024-10-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 12.48 | 14.0K | 350,023 | D | ↗ |
| 2024-10-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 78 | 12.48 | 973.44 | 36,216 | D | ↗ |
| 2024-10-02 | Magovcevic-Liebisch Ivana | Director | A-Award | A | Common Stock | 12,800 | 0.00 | — | 12,800 | D | ↗ |
| 2024-10-01 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 1,200 | 12.50 | 15.0K | 295,729 | D | ↗ |
| 2024-10-01 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 1,200 | 12.50 | 15.0K | 46,001 | D | ↗ |
| 2024-10-01 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 1,000 | 12.50 | 12.5K | 34,583 | D | ↗ |
| 2024-09-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 368 | 12.50 | 4.6K | 351,143 | D | ↗ |
| 2024-09-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 12.82 | 14.4K | 351,511 | — | ↗ |
| 2024-09-15 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 78 | 12.82 | 999.96 | 36,294 | — | ↗ |
| 2024-08-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 368 | 13.03 | 4.8K | 352,631 | — | ↗ |
| 2024-08-21 | Sriram Vandana | Officer | F-InKind | D | Common Stock | 927 | 13.15 | 12.2K | 36,372 | — | ↗ |
| 2024-08-20 | WALT DAVID R | Director | P-Purchase | A | Common Stock | 47,000 | 13.29 | 624.6K | 1,487,342 | — | ↗ |
| 2024-08-19 | Elliott Jeffrey Thomas | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-08-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 11.35 | 12.7K | 352,999 | — | ↗ |
| 2024-08-13 | Toloue Masoud | Director / Officer | P-Purchase | A | Common Stock | 19,000 | 10.90 | 207.1K | 354,119 | — | ↗ |
| 2024-07-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 368 | 14.76 | 5.4K | 335,119 | — | ↗ |
| 2024-07-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 15.08 | 16.9K | 335,487 | — | ↗ |
| 2024-07-01 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 1,182 | 12.68 | 15.0K | 294,529 | — | ↗ |
| 2024-07-01 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 1,182 | 12.68 | 15.0K | 44,801 | — | ↗ |
| 2024-07-01 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 985 | 12.68 | 12.5K | 33,583 | — | ↗ |
| 2024-06-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 368 | 13.21 | 4.9K | 336,607 | — | ↗ |
| 2024-06-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 13.32 | 14.9K | 336,975 | — | ↗ |
| 2024-05-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,054 | 15.97 | 16.8K | 338,095 | — | ↗ |
| 2024-05-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 17.88 | 20.0K | 339,149 | — | ↗ |
| 2024-05-14 | OLSON LAURIE J | Director | S-Sale | D | Common Stock | 1,500 | 16.98 | 25.5K | 13,738 | — | ↗ |
| 2024-04-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,049 | 16.12 | 16.9K | 340,269 | — | ↗ |
| 2024-04-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 17.15 | 19.2K | 341,318 | — | ↗ |
| 2024-04-01 | OLSON LAURIE J | Director | M-Exempt | D | Stock Option (Right to Buy) | 1,000 | 12.86 | 12.9K | 10,124 | — | ↗ |
| 2024-04-01 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 630 | 23.78 | 15.0K | 293,347 | — | ↗ |
| 2024-04-01 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 630 | 23.78 | 15.0K | 43,619 | — | ↗ |
| 2024-04-01 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 525 | 23.78 | 12.5K | 32,598 | — | ↗ |
| 2024-03-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 23.56 | 26.4K | 342,438 | — | ↗ |
| 2024-03-15 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 1,120 | 26.55 | 29.7K | 343,558 | — | ↗ |
| 2024-02-29 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 724 | 23.96 | 17.3K | 344,678 | — | ↗ |
| 2024-02-14 | OLSON LAURIE J | Director | S-Sale | D | Common Stock | 1,500 | 24.35 | 36.5K | 15,238 | — | ↗ |
| 2024-02-02 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 8,397 | 23.10 | 194.0K | 345,402 | — | ↗ |
| 2024-02-02 | Sriram Vandana | Officer | A-Award | A | Stock Option (right to buy) | 83,038 | 23.10 | 1.92M | 83,038 | — | ↗ |
| 2024-01-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 763 | 22.09 | 16.9K | 286,267 | — | ↗ |
| 2024-01-02 | WALT DAVID R | Director | A-Award | A | Common Stock | 2,947 | 0.00 | — | 1,442,342 | — | ↗ |
| 2024-01-02 | OLSON LAURIE J | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2024-01-02 | Madaus Martin D | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2024-01-02 | MEISTER PAUL M | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2024-01-02 | Hlavinka Sarah E. | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2024-01-02 | Flynn Karen | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2024-01-02 | DONNELLY WILLIAM P | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2024-01-02 | Blaser Brian J | Director | A-Award | A | Stock Option (Right to Buy) | 6,412 | 27.15 | 174.1K | 6,412 | — | ↗ |
| 2023-12-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 859 | 27.34 | 23.5K | 287,030 | — | ↗ |
| 2023-11-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 23.97 | 15.3K | 287,889 | — | ↗ |
| 2023-10-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 21.72 | 13.9K | 288,527 | — | ↗ |
| 2023-10-02 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 561 | 26.71 | 15.0K | 289,218 | — | ↗ |
| 2023-10-02 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 561 | 26.71 | 15.0K | 39,490 | — | ↗ |
| 2023-10-02 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 228 | 26.71 | 6.1K | 28,666 | — | ↗ |
| 2023-09-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 27.14 | 17.3K | 289,165 | — | ↗ |
| 2023-09-30 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 117 | 27.14 | 3.2K | 88,332 | — | ↗ |
| 2023-09-08 | DONNELLY WILLIAM P | Director | P-Purchase | A | Common Stock | 20,200 | 24.85 | 502.0K | 28,438 | — | ↗ |
| 2023-08-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 26.80 | 17.1K | 289,803 | — | ↗ |
| 2023-08-31 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 117 | 26.80 | 3.1K | 88,449 | — | ↗ |
| 2023-08-21 | Sriram Vandana | Officer | A-Award | A | Stock Option (right to buy) | 29,455 | 24.32 | 716.3K | 29,455 | — | ↗ |
| 2023-08-17 | DONNELLY WILLIAM P | Director | A-Award | A | Common Stock | 8,238 | 0.00 | — | 8,238 | — | ↗ |
| 2023-07-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 24.84 | 15.8K | 290,441 | — | ↗ |
| 2023-07-31 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 117 | 24.84 | 2.9K | 88,566 | — | ↗ |
| 2023-07-03 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 687 | 21.82 | 15.0K | 288,657 | — | ↗ |
| 2023-07-03 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 687 | 21.82 | 15.0K | 38,929 | — | ↗ |
| 2023-06-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 22.55 | 14.4K | 291,079 | — | ↗ |
| 2023-06-30 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 117 | 22.55 | 2.6K | 88,683 | — | ↗ |
| 2023-06-07 | MEISTER PAUL M | Director | M-Exempt | A | Common Stock | 23,335 | 2.89 | 67.4K | 287,970 | — | ↗ |
| 2023-05-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 19.61 | 12.5K | 291,717 | — | ↗ |
| 2023-05-31 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 117 | 19.61 | 2.3K | 88,800 | — | ↗ |
| 2023-04-30 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 638 | 12.64 | 8.1K | 292,355 | — | ↗ |
| 2023-04-30 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 119 | 12.64 | 1.5K | 88,917 | — | ↗ |
| 2023-04-25 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 2,683 | 11.67 | 31.3K | 292,993 | — | ↗ |
| 2023-04-07 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 1,006 | 12.63 | 12.7K | 89,036 | — | ↗ |
| 2023-04-03 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 1,344 | 11.16 | 15.0K | 264,635 | — | ↗ |
| 2023-04-03 | Hlavinka Sarah E. | Director | A-Award | A | Common Stock | 1,344 | 11.16 | 15.0K | 38,242 | — | ↗ |
| 2023-04-03 | CRANDELL KEITH | Director | A-Award | A | Common Stock | 1,170 | 11.16 | 13.1K | 131,236 | — | ↗ |
| 2023-03-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 414 | 11.27 | 4.7K | 295,676 | — | ↗ |
| 2023-03-31 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 35 | 11.27 | 394.45 | 90,042 | — | ↗ |
| 2023-03-09 | WALT DAVID R | Director | G-Gift | D | Common Stock | 1,000 | 0.00 | — | 1,440,342 | — | ↗ |
| 2023-02-28 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 418 | 11.00 | 4.6K | 296,090 | — | ↗ |
| 2023-02-28 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 41 | 11.00 | 451.00 | 90,077 | — | ↗ |
| 2023-02-02 | Toloue Masoud | Director / Officer | A-Award | A | Common Stock | 111,178 | 0.00 | — | 296,508 | — | ↗ |
| 2023-02-02 | DOYLE MICHAEL A | Officer | A-Award | A | Stock Option (right to buy) | 97,281 | 14.82 | 1.44M | 97,281 | — | ↗ |
| 2023-01-31 | Toloue Masoud | Director / Officer | F-InKind | D | Common Stock | 493 | 14.13 | 7.0K | 185,330 | — | ↗ |
| 2023-01-31 | DOYLE MICHAEL A | Officer | F-InKind | D | Common Stock | 41 | 14.13 | 579.33 | 48,426 | — | ↗ |
| 2023-01-06 | Blaser Brian J | Director | A-Award | A | Common Stock | 16,102 | 0.00 | — | 16,102 | — | ↗ |
| 2023-01-03 | WALT DAVID R | Director | A-Award | A | Common Stock | 8,083 | 0.00 | — | 1,439,395 | — | ↗ |
| 2023-01-03 | OLSON LAURIE J | Director | A-Award | A | Common Stock | 8,083 | 0.00 | — | 15,291 | — | ↗ |
| 2023-01-03 | Madaus Martin D | Director | A-Award | A | Stock Option (Right to Buy) | 12,124 | 0.00 | — | 12,124 | — | ↗ |
| 2023-01-03 | MEISTER PAUL M | Director | A-Award | A | Common Stock | 1,166 | 12.86 | 15.0K | 263,291 | — | ↗ |
| 2023-01-03 | Hlavinka Sarah E. | Director | A-Award | A | Stock Option (Right to Buy) | 12,124 | 0.00 | — | 12,124 | — | ↗ |
| 2023-01-03 | Flynn Karen | Director | A-Award | A | Stock Option (Right to Buy) | 12,124 | 0.00 | — | 12,124 | — | ↗ |
| 2023-01-03 | CRANDELL KEITH | Director | A-Award | A | Stock Option (Right to Buy) | 12,124 | 0.00 | — | 12,124 | — | ↗ |
| 2022-12-31 | DOYLE MICHAEL A | Director | F-InKind | D | Common Stock | 42 | 13.85 | 581.70 | 48,467 | — | ↗ |
| 2022-11-30 | DOYLE MICHAEL A | Director | F-InKind | D | Common Stock | 35 | 13.30 | 465.50 | 48,509 | — | ↗ |
| 2022-11-03 | DOYLE MICHAEL A | Director | F-InKind | D | Common Stock | 35 | 11.07 | 387.45 | 48,544 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-233.2K
Shares Outstanding
46.94M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Masoud Toloue, Ph.D. Former President and Chief Executive Officer | 671.0K | — | 1.17M | 2.73M | 674.2K | 5.6K | 5.25M | 74.28% | ↗ |
| 2 | 2025 | Vandana Sriram Chief Financial Officer and Treasurer | 462.3K | — | 427.5K | 997.5K | 309.2K | 15.8K | 2.21M | 64.41% | ↗ |
| 3 | 2025 | William P. Donnelly Former Executive Chair | 19.3K | — | 80.0K | 408.1K | — | 89.4K | 596.8K | 81.78% | ↗ |
| 4 | 2024 | Masoud Toloue, Ph.D. President and Chief Executive Officer | 642.8K | — | 1.56M | 3.64M | 585.0K | 5.2K | 6.43M | 80.83% | ↗ |
| 5 | 2024 | Masoud Toloue, Ph.D. Former President and Chief Executive Officer | 642.8K | — | 1.56M | 3.64M | 585.0K | 5.2K | 6.43M | 80.83% | ↗ |
| 6 | 2024 | Vandana Sriram Chief Financial Officer and Treasurer | 446.2K | — | 570.0K | 1.33M | 255.8K | 15.5K | 2.62M | 72.59% | ↗ |
| 7 | 2023 | Masoud Toloue, Ph.D. Former President and Chief Executive Officer | 615.4K | — | 1.65M | 2.35M | 810.0K | 9.9K | 5.44M | 73.59% | ↗ |
| 8 | 2023 | Masoud Toloue, Ph.D. President and Chief Executive Officer | 615.4K | — | 1.65M | 2.35M | 810.0K | 9.9K | 5.44M | 73.59% | ↗ |
| 9 | 2023 | Michael A. Doyle Former Chief Financial Officer and Former Executive Director, Finance | 448.3K | — | 617.9K | 882.1K | 165.0K | 9.9K | 2.12M | 70.65% | ↗ |
| 10 | 2023 | Vandana Sriram Chief Financial Officer and Treasurer | 144.1K | — | 307.0K | 493.0K | 151.5K | 3.6K | 1.10M | 72.78% | ↗ |
| 11 | 2022 | Masoud Toloue, Ph.D. President and Chief Executive Officer | 541.3K | — | 892.1K | 1.11M | 412.5K | 3.2K | 2.96M | 67.64% | ↗ |
| 12 | 2022 | E. Kevin Hrusovsky Former Executive Chairman and Chief Executive Officer | 361.7K | — | 624.5K | 775.5K | — | 159.8K | 1.92M | 72.86% | ↗ |
| 13 | 2022 | Michael A. Doyle Former Chief Financial Officer and Former Executive Director, Finance | 419.8K | — | 401.5K | 498.5K | 142.1K | 8.2K | 1.47M | 61.22% | ↗ |
| 14 | 2022 | Michael A. Doyle Chief Financial Officer and Treasurer | 419.8K | — | 401.5K | 498.5K | 142.1K | 8.2K | 1.47M | 61.22% | ↗ |
| 15 | 2022 | Mark T. Roskey, Ph.D. Chief Science and Collaboration Officer | 353.4K | — | 342.9K | 442.5K | 133.5K | 8.1K | 1.28M | 61.34% | ↗ |
| 16 | 2022 | John Fry Former General Counsel and Secretary | 274.3K | — | 267.7K | 332.3K | — | 7.3K | 881.6K | 68.06% | ↗ |
| 17 | 2021 | E. Kevin Hrusovsky Former Executive Chairman and Chief Executive Officer | 592.6K | — | 1.43M | 1.58M | 596.6K | 10.5K | 4.21M | 71.49% | ↗ |
| 18 | 2021 | E. Kevin Hrusovsky Executive Chairman and Former Chief Executive Officer | 592.6K | — | 3.01M | — | 596.6K | 10.5K | 4.21M | 71.49% | ↗ |
| 19 | 2021 | Masoud Toloue, Ph.D. President and Chief Executive Officer | 278.7K | — | 3.06M | — | 298.8K | — | 3.64M | 84.13% | ↗ |
| 20 | 2021 | Masoud Toloue, Ph.D. President and Chief Executive Officer; Former President of Quanterix and Diagnostics | 278.7K | — | 3.06M | — | 298.8K | — | 3.64M | 84.13% | ↗ |
| 21 | 2021 | William Geist Former Chief Operating Officer | 361.5K | — | 802.3K | — | — | 756.4K | 1.92M | 41.78% | ↗ |
| 22 | 2021 | John Fry General Counsel and Secretary | 362.4K | — | 601.7K | — | 173.0K | 8.8K | 1.15M | 52.51% | ↗ |
| 23 | 2021 | John Fry Former General Counsel and Secretary | 362.4K | — | 286.2K | 315.5K | 173.0K | 8.8K | 1.15M | 52.51% | ↗ |
| 24 | 2021 | Dawn R. Mattoon, Ph.D. Senior Vice President, Clinical Diagnostics | 342.6K | — | 601.7K | — | 189.5K | 8.7K | 1.14M | 52.67% | ↗ |
| 25 | 2021 | Amol Chaubal Former Chief Financial Officer | 156.0K | — | 946.7K | — | — | 4.1K | 1.11M | 85.53% | ↗ |
| 26 | 2021 | Michael A. Doyle Chief Financial Officer | 183.6K | — | 730.8K | — | 99.8K | — | 1.01M | 72.06% | ↗ |
| 27 | 2021 | Michael A. Doyle Former Chief Financial Officer and Former Executive Director, Finance | 183.6K | — | 330.0K | 400.8K | 99.8K | — | 1.01M | 72.06% | ↗ |
| 28 | 2021 | Michael A. Doyle Chief Financial Officer and Treasurer | 183.6K | — | 330.0K | 400.8K | 99.8K | — | 1.01M | 72.06% | ↗ |
| 29 | 2021 | Shawn Stetson Former Interim Chief Financial Officer | 221.1K | — | 224.9K | — | 46.7K | 6.6K | 499.3K | 45.05% | ↗ |
| 30 | 2020 | E. Kevin Hrusovsky Former Executive Chairman and Chief Executive Officer | 554.3K | 769.4K | 1.08M | 1.10M | — | 10.7K | 3.52M | 62.10% | ↗ |
| 31 | 2020 | E. Kevin Hrusovsky Chairman, President and Chief Executive Officer | 554.3K | 769.4K | 1.08M | 1.10M | — | 10.7K | 3.52M | 62.10% | ↗ |
| 32 | 2020 | E. Kevin Hrusovsky Executive Chairman and Former Chief Executive Officer | 554.3K | 769.4K | 2.19M | — | — | 10.7K | 3.52M | 62.10% | ↗ |
| 33 | 2020 | William Geist Former Chief Operating Officer | 52.3K | 530.0K | 1.90M | — | — | 1.3K | 2.48M | 76.51% | ↗ |
| 34 | 2020 | William Geist Chief Operating Officer | 52.3K | 530.0K | 1.90M | — | — | 1.3K | 2.48M | 76.51% | ↗ |
| 35 | 2020 | Amol Chaubal Former Chief Financial Officer | 371.2K | 331.0K | 520.5K | — | — | 4.2K | 1.23M | 42.43% | ↗ |
| 36 | 2020 | Amol Chaubal Chief Financial Officer | 371.2K | 331.0K | 257.8K | 262.7K | — | 4.2K | 1.23M | 42.43% | ↗ |
| 37 | 2020 | John Fry Former General Counsel and Secretary | 354.6K | 239.9K | 309.3K | 315.3K | — | 5.9K | 1.23M | 50.99% | ↗ |
| 38 | 2020 | John Fry General Counsel and Secretary | 354.6K | 239.9K | 624.6K | — | — | 5.9K | 1.23M | 50.99% | ↗ |
| 39 | 2020 | Dawn R. Mattoon, Ph.D. Senior Vice President, Clinical Diagnostics | 330.9K | 239.9K | 624.6K | — | — | 9.3K | 1.20M | 51.84% | ↗ |
| 40 | 2020 | Shawn Stetson Former Interim Chief Financial Officer | 205.0K | 60.9K | 56.8K | — | — | 6.2K | 328.9K | 17.26% | ↗ |
| 41 | 2019 | E. Kevin Hrusovsky Chairman, President and | 532.0K | 770.0K | 1.00M | 1.31M | — | 9.7K | 3.63M | 63.88% | ↗ |
| 42 | 2019 | E. Kevin Hrusovsky Executive Chairman and Former Chief Executive Officer | 532.0K | 770.0K | 2.32M | — | — | 9.7K | 3.63M | 63.88% | ↗ |
| 43 | 2019 | E. Kevin Hrusovsky Chairman, President and Chief Executive Officer | 532.0K | 770.0K | 1.00M | 1.31M | — | 9.7K | 3.63M | 63.88% | ↗ |
| 44 | 2019 | John Fry General Counsel and Secretary | 192.2K | 115.3K | 753.4K | 619.0K | — | 5.4K | 1.69M | 81.43% | ↗ |
| 45 | 2019 | John Fry General Counsel and Secretary | 192.2K | 115.3K | 1.37M | — | — | 5.4K | 1.69M | 81.43% | ↗ |
| 46 | 2019 | Amol Chaubal Chief Financial Officer | 253.1K | 145.8K | 414.5K | 525.8K | — | 4.3K | 1.34M | 69.99% | ↗ |
| 47 | 2019 | Amol Chaubal Former Chief Financial Officer | 253.1K | 145.8K | 940.3K | — | — | 4.3K | 1.34M | 69.99% | ↗ |
| 48 | 2019 | Dawn R. Mattoon, Ph.D. Senior Vice President, Clinical Diagnostics | 314.5K | 190.5K | 371.7K | — | — | 8.9K | 885.6K | 41.97% | ↗ |
| 49 | 2019 | Shawn Stetson Former Interim Chief Financial Officer | 95.3K | 34.5K | 112.4K | — | — | 2.7K | 244.8K | 45.90% | ↗ |
| 50 | 2018 | E. Kevin Hrusovsky Chairman, President and | 497.9K | 609.4K | 4.44M | — | — | 346.00 | 5.55M | 80.03% | ↗ |
| 51 | 2018 | Dawn R. Mattoon, Ph.D. Senior Vice President, Clinical Diagnostics | 239.1K | 134.0K | 368.0K | 558.2K | — | 3.1K | 1.30M | 71.12% | ↗ |
| 52 | 2018 | Jackson Streeter, M.D. | 41.5K | 20.8K | 464.4K | 409.4K | — | 1.2K | 937.4K | 93.22% | ↗ |
| 53 | 2017 | E. Kevin Hrusovsky Chairman, President and | 427.0K | 276.7K | — | 1.43M | — | — | 2.13M | 67.02% | ↗ |
| 54 | 2017 | Joseph Driscoll | 201.9K | 96.9K | — | 1.37M | — | — | 1.67M | 82.07% | ↗ |
| 55 | 2017 | David C. Duffy, Ph.D. | 222.3K | 76.7K | — | 212.9K | — | — | 511.9K | 41.58% | ↗ |
| 56 | 2016 | E. Kevin Hrusovsky Chairman, President and | 411.0K | 137.5K | — | — | — | — | 548.5K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Everett V. Cunningham | President, Chief Executive Officer & Director | 1M | male |
| Vandana Sriram | Chief Financial Officer & Treasurer | 787.2K | female |
| William Donnelly | Executive Chair | 258.6K | male |
| David R. Walt | Co-Founder & Chairman of Scientific Advisory Board | 50.9K | — |
| Laurie A. Churchill | Senior Vice President, General Counsel & Secretary | — | female |
| Michael Miller | Chief Operating Officer | — | — |
| Naren Bhat | Senior Vice President of Corporate Development & Strategy | — | male |
| Joshua Young | Head of Investor Relations | — | — |
| Erica Bell | Chief People Officer | — | female |
| Jerzy Olejnik | Chief Technology Officer | — | male |
| Daniel S. Char | Chief Legal Officer & Corporate Secretary | — | male |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for QTRX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
